Arcadia Biosciences (RKDA) Cash & Current Investments (2014 - 2025)

Arcadia Biosciences has reported Cash & Current Investments for 12 years, with the latest figure at $4.6 million in Q4 2025.

• For the quarter ending Q4 2025, Cash & Current Investments rose 8.53% year-over-year to $4.6 million; the trailing twelve-month figure through Dec 2025 stood at $4.6 million (up 8.53% YoY), and the FY2025 full-year result was $4.6 million, up 8.53% from the prior year.
• Cash & Current Investments for Q4 2025 stood at $4.6 million, down from $5.9 million in the prior quarter.
• The five-year high for Cash & Current Investments was $51.9 million in Q1 2021, with the low at $3.2 million in Q1 2025.
• Historically, Cash & Current Investments has averaged $18.2 million across 5 years, with a median of $17.1 million in 2023.
• Annual changes were most pronounced in 2021 — Cash & Current Investments surged 340.55% — and 2024, when it sank 63.56%.
• Arcadia Biosciences' Cash & Current Investments stood at $28.7 million in 2021, then dropped by 28.03% to $20.6 million in 2022, then plunged by 43.61% to $11.6 million in 2023, then slumped by 63.56% to $4.2 million in 2024, then grew by 8.53% to $4.6 million in 2025.
• The last three Cash & Current Investments figures came in at $4.6 million (Q4 2025), $5.9 million (Q3 2025), and $4.5 million (Q2 2025), per Business Quant data.